ArticleEBioMedicine2016

A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition.

Valentina Labanca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.